Ayala Pharmaceuticals Inc (ADXS)

[cab033]

Oh I guess you were not here in 2015 when this rose from $7 in Feb to $30 in early June, just before ASCO? Oh wait, yes you were. Maybe you forgot about that, or attibute it to something else. What real data has ADXS released over the past 2 ASCO events? Need a hint, I think that would be zero. Might contribute to now drift up. But this year, they might actually have new data to release that casuses some excitement.

So do you see the only 2 options for ADXS as being masively dilute now or sell the company? Really? And you think those options are more realistic than releasing good combo data at the largest event of the year?